Bio Preventive Medicine Corp. (TPEX:6810)
19.40
-1.10 (-5.37%)
Nov 20, 2026, 1:57 PM CST
Bio Preventive Medicine Market Cap
Bio Preventive Medicine has a market cap or net worth of 959.3 million as of November 20, 2026. It is the 33,583rd most valuable company in the world and the 1,992nd biggest in Taiwan. Its market cap has decreased by 16.38% in one year.
Market Cap
959.30M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#1,992 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since August 30, 2021, Bio Preventive Medicine's market cap has increased from 711.01M to 959.30M, an increase of 34.92%. That is a compound annual growth rate of 5.90%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 969.19M | -16.24% |
| Dec 31, 2025 | 1.16B | -22.00% |
| Dec 31, 2024 | 1.48B | 13.92% |
| Dec 29, 2023 | 1.30B | 8.31% |
| Dec 30, 2022 | 1.20B | -4.26% |
| Dec 30, 2021 | 1.26B | 76.61% |
| Aug 30, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Andros Pharmaceuticals Co.,Ltd | 1.16B |
| Advagene Biopharma | 1.15B |
| Abnova (Taiwan) | 1.06B |
| Sunny Pharmtech | 1.03B |
| LabTurbo Biotech | 988.28M |
| Level Biotechnology | 921.66M |
| Enimmune | 914.62M |
| BiOptic | 866.92M |